Physician
Shahab a Malik MD, LLC.
Shahab a Malik MD, LLC. was paid $7.98M by Medicaid between Feb 2018 and Nov 2024, across 56 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 45% of everything it billed.
33Billing provider infoSHAHAB A MALIK MD, LLC.
GLEN BURNIE, MD 21061
GLEN BURNIE, MD 21061
33aNPI1740329507assigned 02/06/2007
33bProvider typePediatrics Physician
28Total paid$7.98M
24GClaims208,200
24DCodes billed56
24AFirst – last monthFeb 2018 – Nov 2024
Compared with peers
Next to other Pediatrics Physician providers in Maryland
Rank by total paid#10 of 306
Median peer was paid$206K
This provider vs. median39×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,785 | $71K | |
| 2019 | 1,064 | $27K | |
| 2020 | 29,740 | $983K | |
| 2021 | 54,612 | $1.63M | |
| 2022 | 48,893 | $1.84M | |
| 2023 | 38,792 | $1.77M | |
| 2024incomplete | 32,314 | $1.67M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 45% | 55,557 | 41,765 | $3.56M |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 8.8% | 8,206 | 7,538 | $706K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 8.1% | 7,682 | 7,008 | $643K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 7.2% | 4,938 | 4,370 | $573K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 7.1% | 5,763 | 5,353 | $570K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 5.8% | 5,989 | 5,297 | $460K |
| D1206 | Topical application of fluoride varnish | 2.7% | 8,775 | 7,092 | $212K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.4% | 11,257 | 10,136 | $113K |
| 92551 | 1.4% | 13,544 | 12,452 | $110K | |
| 90698 | 1.0% | 4,626 | 4,173 | $82K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 1.0% | 683 | 662 | $81K |
| 90670 | <1% | 4,015 | 3,584 | $68K |
44 more codes
| 90688 | <1% | 3,607 | $62K | |
| 90680 | <1% | 3,105 | $57K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 6,560 | $54K |
| 90677 | <1% | 902 | $50K | |
| 92552 | <1% | 2,833 | $48K | |
| 90633 | <1% | 2,340 | $46K | |
| 99381 | <1% | 576 | $46K | |
| 90744 | <1% | 2,237 | $45K | |
| 90734 | <1% | 1,902 | $40K | |
| 90710 | <1% | 2,002 | $39K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 1,063 | $37K |
| 36415 | Collection of venous blood by venipuncture | <1% | 16,106 | $35K |
| 99173 | <1% | 16,401 | $35K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 3,531 | $25K |
| 90651 | <1% | 1,194 | $25K | |
| 90696 | <1% | 988 | $22K | |
| 90715 | <1% | 995 | $22K | |
| 90658 | <1% | 1,361 | $21K | |
| 36410 | <1% | 1,766 | $12K | |
| 90687 | <1% | 582 | $11K | |
| 87807 | <1% | 1,116 | $9K | |
| 0071A | <1% | 391 | $8K | |
| 0072A | <1% | 352 | $7K | |
| 90657 | <1% | 467 | $7K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 450 | $6K |
| 90649 | <1% | 248 | $6K | |
| 90707 | <1% | 246 | $5K | |
| 90716 | <1% | 245 | $5K | |
| 36406 | <1% | 286 | $3K | |
| 0001A | <1% | 128 | $3K | |
| 0002A | <1% | 81 | $3K | |
| 69210 | <1% | 58 | $3K | |
| 0004A | <1% | 54 | $2K | |
| 81002 | <1% | 867 | $2K | |
| 36416 | <1% | 642 | $2K | |
| 90621 | <1% | 43 | $1K | |
| 87809 | <1% | 44 | $702.38 | |
| 84030 | <1% | 371 | $627.93 | |
| A4250 | Urine test or reagent strips or tablets (100 tablets or strips) | <1% | 85 | $520.00 |
| 99051 | <1% | 36 | $350.00 | |
| 99050 | <1% | 16 | $120.00 | |
| 81005 | <1% | 69 | $56.86 | |
| 91307 | <1% | 557 | $9.02 | |
| 91300 | <1% | 262 | $0.03 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMALIK, SHAHAB (CHAIRMAN)